跳至主要内容
临床试验/EUCTR2009-011006-42-DK
EUCTR2009-011006-42-DK进行中(未招募)1 期

Sildenafil and diastolic dysfunction after AMI - SIDAMI

Rigshospitalet, Hjertemedicinsk afd. B0 个研究点目标入组 70 人开始时间: 2009年6月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ·Age >50 years
  • ·Recent AMI (within 21 days) defined according to ESC/ACC guidelines
  • ·Doppler echocardiographic signs of elevated filling pressures defined as
  • odiastolic E/e’ ratio >15, or
  • odiastolic E/e’ ratio 8-15 and left atrial volume index>32 ml/m2
  • ·Preserved LV systolic function (WMSI>1.3)
  • ·Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ·Ongoing myocardial ischemia
  • ·Ongoing treatment with nitrates.
  • ·Poor echocardiographic window
  • ·Inability to exercise
  • ·Permanent atrial fibrillation or paced rhythm
  • ·Planned coronary artery bypass grafting
  • ·Other noncardiac condition with expected survival less than 6 months
  • ·Unwilling to participate
  • ·Known intolerance to sildenafil

研究者

发起方
Rigshospitalet, Hjertemedicinsk afd. B

相似试验